FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation - fda.gov

FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation - fda.gov
Business

Listen to this article

0%

For Immediate Release: January 11, 2026 The U.S. Food and Drug Administration today announced it is sharing information about the agencys flexible approach to overseeing chemistry, manufacturing an… [+3405 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected